Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

AHPA Modifies Ephedra Petition To Specify Two Chinese Herbals

This article was originally published in The Tan Sheet

Executive Summary

The American Herbal Products Association is modifying a petition to stay FDA's ephedra ban by highlighting two Chinese herbal ingredients that the group feels are wrongly included

You may also be interested in...



AHPA Seeks Ephedra Rule Stay For Traditional Herbs Labeled As Supplements

AHPA has petitioned the FDA to stay its ephedra ban "only insofar as it pertains to traditional herbal formulas" marketed to licensed health care practitioners

Ephedra Ban Effective In April; FDA Will Follow-Up On Internet Firms

A 1final rule prohibiting the sale of dietary supplements containing ephedrine alkaloids will become effective April 12, FDA announced Feb. 6

Supplement GMP Warning Letters Make Modest Debut In 2010

Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC

Topics

UsernamePublicRestriction

Register

LL1133546

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel